Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Atossa Genetics, Inc. (ATOS) Starts Presentation at LD Micro Conference

Atossa Genetics works as a healthcare company focused on the development of a laboratory services, medical devices and therapeutics for breast cancer in the U.S. ATOS markets nipple aspirate fluid (NAF) cytology and pharmacogenomics tests. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator devices that are used for collecting of NAF for cytological laboratory testing.  Founded in 2009, the company is based in Seattle, Washington.  For more information, visit the company’s website at

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.